AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

AMS:AKZA • NL0013267909

60.42 EUR
-0.4 (-0.66%)
Last: Feb 16, 2026, 05:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

AKZA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. AKZA has an average financial health and profitability rating. AKZA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • AKZA had positive earnings in the past year.
  • AKZA had a positive operating cash flow in the past year.
  • Each year in the past 5 years AKZA has been profitable.
  • Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • The Return On Assets of AKZA (4.55%) is better than 66.67% of its industry peers.
  • AKZA has a Return On Equity of 13.63%. This is in the better half of the industry: AKZA outperforms 76.81% of its industry peers.
  • AKZA's Return On Invested Capital of 8.24% is fine compared to the rest of the industry. AKZA outperforms 71.01% of its industry peers.
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROIC 8.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • AKZA has a Profit Margin of 6.25%. This is in the better half of the industry: AKZA outperforms 65.22% of its industry peers.
  • In the last couple of years the Profit Margin of AKZA has declined.
  • Looking at the Operating Margin, with a value of 11.46%, AKZA is in the better half of the industry, outperforming 72.46% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
  • AKZA has a Gross Margin (39.86%) which is in line with its industry peers.
  • AKZA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKZA is creating some value.
  • AKZA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.37 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.37, AKZA perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
  • AKZA has a debt to FCF ratio of 8.04. This is a slightly negative value and a sign of low solvency as AKZA would need 8.04 years to pay back of all of its debts.
  • The Debt to FCF ratio of AKZA (8.04) is better than 60.87% of its industry peers.
  • AKZA has a Debt/Equity ratio of 0.79. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of AKZA (0.79) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Altman-Z 2.37
ROIC/WACC1.22
WACC6.76%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that AKZA should not have too much problems paying its short term obligations.
  • The Current ratio of AKZA (1.44) is worse than 66.67% of its industry peers.
  • AKZA has a Quick Ratio of 1.08. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • AKZA has a Quick ratio of 1.08. This is comparable to the rest of the industry: AKZA outperforms 46.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.08
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.43%.
  • Measured over the past years, AKZA shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.32% on average per year.
  • AKZA shows a decrease in Revenue. In the last year, the revenue decreased by -5.16%.
  • The Revenue has been growing slightly by 3.56% on average over the past years.
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%

3.2 Future

  • AKZA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
  • The Revenue is expected to grow by 5.95% on average over the next years.
EPS Next Y20.5%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
EPS Next 5Y13.72%
Revenue Next Year-0.83%
Revenue Next 2Y2.41%
Revenue Next 3Y5.79%
Revenue Next 5Y5.95%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.60 indicates a correct valuation of AKZA.
  • AKZA's Price/Earnings ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 73.91% of the companies in the same industry.
  • AKZA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.68.
  • AKZA is valuated correctly with a Price/Forward Earnings ratio of 13.77.
  • Based on the Price/Forward Earnings ratio, AKZA is valued cheaper than 81.16% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, AKZA is valued rather cheaply.
Industry RankSector Rank
PE 16.6
Fwd PE 13.77
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • AKZA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 68.12% of the companies in the same industry.
  • AKZA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AKZA is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.08
EV/EBITDA 8.46
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • AKZA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AKZA's earnings are expected to grow with 14.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y14.97%
EPS Next 3Y14.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • AKZA has a Yearly Dividend Yield of 3.27%.
  • Compared to an average industry Dividend Yield of 2.15, AKZA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.84, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 60.16% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP60.16%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AKZO NOBEL N.V.

AMS:AKZA (2/16/2026, 5:29:59 PM)

60.42

-0.4 (-0.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)04-21
Inst Owners73.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap10.33B
Revenue(TTM)10.16B
Net Income(TTM)635.00M
Analysts76
Price Target69.93 (15.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP60.16%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.39%
Min EPS beat(2)-33.37%
Max EPS beat(2)-7.4%
EPS beat(4)0
Avg EPS beat(4)-12.83%
Min EPS beat(4)-33.37%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-7.59%
EPS beat(12)2
Avg EPS beat(12)-8.15%
EPS beat(16)3
Avg EPS beat(16)-13.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-1.97%
Revenue beat(12)3
Avg Revenue beat(12)-1.59%
Revenue beat(16)3
Avg Revenue beat(16)-1.66%
PT rev (1m)-0.45%
PT rev (3m)-1.64%
EPS NQ rev (1m)-10.95%
EPS NQ rev (3m)-12.27%
EPS NY rev (1m)-3.55%
EPS NY rev (3m)-4.7%
Revenue NQ rev (1m)-2.72%
Revenue NQ rev (3m)-10.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 16.6
Fwd PE 13.77
P/S 1.02
P/FCF 17.08
P/OCF 11.31
P/B 2.22
P/tB 12
EV/EBITDA 8.46
EPS(TTM)3.64
EY6.02%
EPS(NY)4.39
Fwd EY7.26%
FCF(TTM)3.54
FCFY5.85%
OCF(TTM)5.34
OCFY8.84%
SpS59.39
BVpS27.24
TBVpS5.03
PEG (NY)0.81
PEG (5Y)N/A
Graham Number47.23
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROCE 11.94%
ROIC 8.24%
ROICexc 10.26%
ROICexgc 19.94%
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
FCFM 5.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Debt/EBITDA 2.38
Cap/Depr 81.75%
Cap/Sales 3.04%
Interest Coverage 7.19
Cash Conversion 59.27%
Profit Quality 95.28%
Current Ratio 1.44
Quick Ratio 1.08
Altman-Z 2.37
F-Score5
WACC6.76%
ROIC/WACC1.22
Cap/Depr(3y)81.45%
Cap/Depr(5y)81.15%
Cap/Sales(3y)2.86%
Cap/Sales(5y)2.86%
Profit Quality(3y)116.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
EPS Next Y20.5%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
EPS Next 5Y13.72%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%
Revenue Next Year-0.83%
Revenue Next 2Y2.41%
Revenue Next 3Y5.79%
Revenue Next 5Y5.95%
EBIT growth 1Y26.94%
EBIT growth 3Y18.02%
EBIT growth 5Y3.86%
EBIT Next Year40.21%
EBIT Next 3Y15.85%
EBIT Next 5Y23.55%
FCF growth 1Y67.13%
FCF growth 3YN/A
FCF growth 5Y-8.8%
OCF growth 1Y36.83%
OCF growth 3Y53.24%
OCF growth 5Y-5.57%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 6 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 5 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 20.5% in the next year.